Recombinant DNA Technology and Transgenic Organisms

Q1 — Sample Band 6 response (7 marks), annotated

Recombinant DNA technology is best understood as a four-step toolchain rather than a single event: cut, join, insert, use. [1 — toolchain framing, four steps named]

In the first step a restriction enzyme cuts a selected gene out of the donor DNA at a specific recognition sequence and also cuts a vector (commonly a plasmid) at the same site, producing complementary "sticky ends". In the second step, DNA ligase seals the donor fragment into the opened vector, producing one continuous recombinant DNA molecule. [1 — molecules of step 1 and 2 named correctly]

Both enzymes are required because they do different jobs and neither alone is sufficient. A restriction enzyme only cuts; without ligase the fragment and vector would only base-pair through their sticky ends and would fall apart. DNA ligase only seals; without a restriction enzyme there are no compatible fragments for it to join. [1 — enzyme pair justified (necessity of both)]

In the third step, the recombinant vector is introduced into a host cell, typically a bacterium such as Escherichia coli. In the fourth step the host cell either replicates the recombinant DNA as it divides (producing many copies of the gene) or expresses it, transcribing and translating the gene to produce its protein product. [1 — host cell and use steps explained]

A vector and a host cell are both needed because the recombinant DNA cannot be replicated or expressed on its own — it needs the molecular machinery (polymerases, ribosomes, energy supply) of a living cell — and the vector is what physically carries the inserted DNA into that cell. Without a vector the gene cannot enter the host; without a host the gene cannot be replicated or expressed. [1 — vector + host both justified]

A worked example is recombinant human insulin. The human insulin gene is cut from human donor DNA with a restriction enzyme; the same enzyme cuts an E. coli plasmid. DNA ligase joins the human gene into the plasmid. The recombinant plasmid is taken up by E. coli, which is then grown in industrial fermenters. The transgenic E. coli express the human insulin gene, producing human insulin protein that is purified for use by diabetic patients. [1 — worked named example mapped to the four steps]

The toolchain is therefore more direct than selective breeding because it can insert chosen DNA into cells rather than relying on existing alleles being reshuffled through reproduction. The process matters: change the donor DNA or the host and you change the application — insulin in bacteria, β-carotene in rice, Bt toxin in cotton — using the same core method. [1 — overall judgement linking process to applications]

Marking criteria.

• 1 mark — Frames recombinant DNA as a four-step toolchain (cut → join → insert → use) rather than a single event.
• 1 mark — Correctly names the molecules of step 1 (restriction enzyme cutting donor and vector at the same recognition sequence, producing sticky ends) and step 2 (DNA ligase sealing the fragment into the vector to make recombinant DNA).
• 1 mark — Justifies why both enzymes are required (restriction enzyme only cuts; ligase only seals; one without the other is non-functional).
• 1 mark — Correctly describes step 3 (insertion into a host cell) and step 4 (replication or expression of the inserted DNA).
• 1 mark — Justifies why both a vector and a host cell are required (vector carries DNA into the cell; host cell provides the molecular machinery to replicate or express).
• 1 mark — Anchors the toolchain in a worked named example (e.g. recombinant insulin in E. coli, Bt cotton, Golden Rice) mapped onto the four steps.
• 1 mark — Closes with an overall judgement linking process to applications (e.g. swapping donor DNA / host changes the application using the same method) and using precise lesson terminology.

Q2 — Sample Band 6 response (8 marks), annotated

Recombinant human insulin (Humulin) is produced using the four-step recombinant DNA toolchain from Card 2: cut, join, insert into a host, and use the result. [1 — applies toolchain framing to the stimulus]

Step 1 — Cut. A restriction enzyme cuts the human insulin gene out of human donor DNA at a specific recognition sequence, and the same enzyme cuts an E. coli plasmid vector, generating compatible sticky ends on both. [1 — step 1 mapped] Step 2 — Join. DNA ligase seals the human insulin gene into the opened plasmid, producing one continuous recombinant DNA molecule. [1 — step 2 mapped]

Step 3 — Insert. The recombinant plasmid is taken up by E. coli host cells. Step 4 — Use. The transgenic E. coli are grown in large fermenters and induced to express the human insulin gene, producing human insulin protein, which is then purified for medical use. [1 — steps 3 + 4 mapped to the stimulus]

So in this application: the donor DNA is the human insulin gene, the vector is a plasmid, the host cell is E. coli, and the product is recombinant human insulin protein. [1 — donor / vector / host / product correctly identified]

This is biologically very different from selective breeding. Selective breeding requires that the trait of interest already exists as an allele somewhere in a population that can interbreed — for example, choosing pigs with desirable characteristics and crossing them. There is no breedable population that produces human insulin, because the human insulin gene does not exist in pigs, cattle, or in E. coli. Selective breeding can only reshuffle alleles that are already present in the breeding pool; it cannot import a gene from one species into another. [1 — transgenic vs selective breeding distinction applied to the case]

The pre-1982 industry confirms this: animal-derived insulin came from pigs or cattle (selective sourcing of animals already producing porcine or bovine insulin) and was structurally different from human insulin by 1–3 amino acids, which is why immune reactions occurred. Recombinant DNA technology overcomes this because it inserts the actual human gene into the host, so the protein produced is identical to human insulin. [1 — links the structural difference of animal vs human insulin to inserted-gene logic]

The critics' claim that "selective breeding could already do this" is therefore not biologically defensible. Selective breeding can refine traits within a breeding population but cannot produce a human protein in a non-human organism, which is exactly what recombinant DNA technology is required for. Production scale, consistency, lower immune reactivity, and reduced dependence on livestock slaughter also follow from this — but the deeper point is methodological: inserted DNA from a different species is a capability selective breeding does not have. [1 — explicit evaluative judgement of the critics' claim]

The Humulin case shows that recombinant DNA technology is not "just complicated selective breeding": it is a different methodological tool, with applications (transgenic medicine, transgenic agriculture, large-scale industrial production of human proteins) that selective breeding simply cannot reach. [1 — final integrated judgement in lesson terminology]

Marking criteria.

• 1 mark — Frames Humulin production as the four-step recombinant DNA toolchain from Card 2.
• 1 mark — Correctly maps Step 1 (restriction enzyme cuts human insulin gene and plasmid with compatible sticky ends).
• 1 mark — Correctly maps Step 2 (DNA ligase seals the gene into the plasmid → recombinant DNA).
• 1 mark — Correctly maps Steps 3 and 4 (recombinant plasmid taken up by E. coli; E. coli grown in fermenters and induced to express the insulin gene; protein purified).
• 1 mark — Identifies all four components in this application: donor DNA = human insulin gene; vector = plasmid; host = E. coli; product = human insulin protein.
• 1 mark — Applies the transgenic-vs-selectively-bred distinction from Card 3: recombinant DNA inserts DNA from another source; selective breeding only reshuffles existing alleles within a breeding population.
• 1 mark — Uses the structural difference between animal insulin (porcine / bovine) and human insulin to show why inserted-DNA methodology was necessary (selective breeding cannot import a gene from one species into another).
• 1 mark — Reaches an explicit evaluative judgement that rejects the critics' claim, in precise lesson terminology (recombinant DNA, vector, host cell, transgenic).

Q3 — Sample Band 6 response (6 marks)

The claim is partly correct in vocabulary but largely flawed in biology. [1 — overall judgement]

What is defensible: Both recombinant DNA technology and selective breeding are processes that combine genetic material from more than one source and can produce offspring with new traits. So in the loosest sense, both involve "DNA from different parents". [1 — concedes the correct element]

What is wrong:

• "Just a cross-bred organism with good traits." A transgenic organism is defined by inserted DNA from another source, often a different species. Selective breeding can only reshuffle alleles that already exist within a breeding population, so the two processes are not equivalent — they involve different mechanisms and different sets of possible outcomes. [1 — refutes "just a cross-bred organism"]
• "Combining DNA from different sources" is the same in both. In selective breeding, DNA is combined only through reproduction between members of the same breeding population. In recombinant DNA technology, DNA from genuinely different sources (e.g. a human gene inserted into E. coli, a maize gene inserted into rice) is physically joined by restriction enzymes and DNA ligase, and carried into a host cell by a vector — this is methodologically and biologically different. [1 — refutes "combining DNA … is the same"]
• "Same biological outcome." The outcomes differ. Recombinant DNA technology can produce traits that do not exist anywhere in the recipient species' gene pool (e.g. Bt-toxin production in cotton, β-carotene in rice grain, human insulin in bacteria) — none of which selective breeding can deliver. [1 — refutes "same outcome" with named example]

Defensible reformulation: "A transgenic organism contains DNA inserted from another source using recombinant DNA technology — a four-step toolchain of restriction-enzyme cutting, DNA-ligase joining, vector-mediated transfer, and host-cell replication or expression. It is therefore not a selectively bred organism. Selective breeding reshuffles alleles that already exist within a breeding population and cannot import a gene from a different species; recombinant DNA technology can. Both are useful, but they are distinct methods with different biological capabilities." [1 — biologically defensible reformulation in precise lesson terminology]

Marking criteria.

• 1 mark — States an overall evaluative judgement (e.g. "partly correct in vocabulary but largely flawed in biology").
• 1 mark — Correctly identifies the one defensible element (both processes combine genetic material from more than one source and can produce offspring with new traits).
• 1 mark — Refutes "just a cross-bred organism" by invoking the lesson definition (transgenic = inserted DNA from another source, often a different species).
• 1 mark — Refutes "combining DNA … is the same" by contrasting reshuffling existing alleles (selective breeding) with restriction enzymes + ligase + vector + host cell (recombinant DNA).
• 1 mark — Refutes "same biological outcome" with at least one named example showing that recombinant DNA technology can produce traits not available to selective breeding (Bt cotton, Golden Rice, recombinant insulin).
• 1 mark — Reformulates the claim into a defensible alternative that uses precise lesson terminology (recombinant DNA, restriction enzyme, ligase, vector, host cell, transgenic) and the toolchain framing.